Life Science Industry Injects More than $910 Million into Mid-Atlantic Project Starts in Second-Quarter 2016
Life Science Industry Injects More than $910 Million into Mid-Atlantic Project Starts in Second-Quarter 2016
SUGAR LAND--March 21, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--When the second quarter of 2016 draws to a close at the end of this month, the U.S. Mid-Atlantic region is forecast to have kicked off construction on 22 projects in the Pharmaceutical & Biotech Industry representing $911 million in total investment value (TIV). Within this article: Descriptions of a plant expansion by Glenmark Pharmaceuticals.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Life Science Sector Injects $2.6 Billion in Mid-Atlantic Project Starts in ...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- Florida Industries Prepare for Hurricane Idalia, a Weather Impact Update
- Moderna Advances U.K. Vaccine Plant After Government Deal
- Ireland's Pharma Sector Boosted by New Investments